Page last updated: 2024-09-03

olmesartan medoxomil and Diarrhea

olmesartan medoxomil has been researched along with Diarrhea in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Janssen, J; Mulder, CJ; Nijeboer, P; van Beurden, YH; Verbeek, WH1
Lopez-Piñeiro, S; Puga-Gimenez, M; Ulla-Rocha, JL1
Araújo, TE; Borba, PB; da Silva, AI; de Araújo Júnior, RF; de Araújo, AA; de Souza, FH; Nogueira, AC; Saldanha, TS1
Gonzalo, DH; Martelli, MG; Naik, DK; Pannu, D; Sharma, AK1
Cartee, AK; Choung, RS; Marietta, EV; Murray, JA; Nadeau, AM; Rishi, A; Rubio-Tapia, A; Singh, I; Wu, TT1
Donnerer, J; Fabian, E; Krejs, GJ; Lackner, C; Schiller, D; Schöfl, R; Silye, R; Wenzl, H; Ziachehabi, A1

Other Studies

6 other study(ies) available for olmesartan medoxomil and Diarrhea

ArticleYear
[Diarrhoea and malabsorption due to olmesartan use].
    Nederlands tijdschrift voor geneeskunde, 2014, Volume: 158

    Topics: Antihypertensive Agents; Atrophy; Celiac Disease; Diagnosis, Differential; Diarrhea; Humans; Hypertension; Imidazoles; Male; Middle Aged; Netherlands; Olmesartan Medoxomil; Tetrazoles

2014
[Acute renal failure secondary to diarrhea due to sprue like-enteropathy associated with olmesartan].
    Gastroenterologia y hepatologia, 2015, Volume: 38, Issue:8

    Topics: Acute Kidney Injury; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Celiac Disease; Diagnosis, Differential; Diarrhea; Endoscopy, Gastrointestinal; Female; Humans; Imidazoles; Malabsorption Syndromes; Olmesartan Medoxomil; Tetrazoles

2015
In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.
    Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Diarrhea; Disease Models, Animal; Imidazoles; Inflammation; Interleukin-1beta; Intestinal Mucosa; Intestine, Small; Male; Methotrexate; Mucositis; Neoplasms; Olmesartan Medoxomil; Rats, Wistar; Sucrose; Tetrazoles; Tumor Necrosis Factor-alpha; Weight Loss

2015
An atypical case of chronic diarrhoea: olmesartan-induced sprue-like enteropathy.
    BMJ case reports, 2015, Sep-14, Volume: 2015

    Topics: Aged, 80 and over; Atrophy; Celiac Disease; Diarrhea; Female; Humans; Imidazoles; Intestinal Diseases; Intestines; Olmesartan Medoxomil; Tetrazoles

2015
Immunopathogenesis of olmesartan-associated enteropathy.
    Alimentary pharmacology & therapeutics, 2015, Volume: 42, Issue:11-12

    Topics: Abdominal Pain; Biopsy; Caco-2 Cells; Celiac Disease; Diarrhea; Duodenum; Female; Humans; Male; Nausea; Olmesartan Medoxomil; T-Lymphocytes, Regulatory; Vomiting

2015
Clinical-Pathological Conference Series from the Medical University of Graz: Case No 156: 82-year-old woman with chronic diarrhea and weight loss of 20 kilograms.
    Wiener klinische Wochenschrift, 2015, Volume: 127, Issue:23-24

    Topics: Aged, 80 and over; Antihypertensive Agents; Chronic Disease; Diagnosis, Differential; Diarrhea; Female; Humans; Intestinal Diseases; Olmesartan Medoxomil; Thinness; Weight Loss

2015